Clinical Trials Logo

Fibrillation, Atrial clinical trials

View clinical trials related to Fibrillation, Atrial.

Filter by:

NCT ID: NCT06200311 Not yet recruiting - Clinical trials for Fibrillation, Atrial

Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men

RACE X
Start date: July 2024
Phase: N/A
Study type: Interventional

The goal of clinical trial is to compare AF ablation to pharmacological rhythm management (being rate or rhythm control) in AF patients with signs of atrial cardiomyopathy (as defined by left atrial volume index >34 ml/m2) The main objective it aims to answer is to determine whether AF ablation compared to pharmacological rhythm management in ACMP patients with AF reduces the incidence of the composite primary endpoint of CV death and first CV hospitalization/urgent visit.

NCT ID: NCT04761315 Completed - Clinical trials for Fibrillation, Atrial

Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)

Start date: January 1, 2015
Phase:
Study type: Observational [Patient Registry]

The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.

NCT ID: NCT04537507 Completed - Clinical trials for Coronary Artery Disease

Atrial Fibrillation and Non-obstructive Coronary Lesions

AF-CAD
Start date: January 2010
Phase:
Study type: Observational

Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with excessive risk of ischemic stroke and heart failure as well as reduced life expectancy. On the other hand, chronic coronary syndromes (CCS) remains the main cause of morbidity and mortality in an aging population. Both disease entities share common risk factors such as hypertension, diabetes and obesity The purpose of the study is to investigate the hypothesis indicating lack of significant coronary lesions in AF vs. sinus rhythm (SR) patients.

NCT ID: NCT03401931 Withdrawn - Clinical trials for Fibrillation, Atrial

Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers

AI Fib
Start date: January 9, 2018
Phase:
Study type: Observational [Patient Registry]

pilot clinical study, multicenter, prospective, open, nonrandomized

NCT ID: NCT00911300 Completed - Clinical trials for Fibrillation, Atrial

Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm

Start date: August 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test whether Fondaparinux is effective and safe to prevent thromboembolic events (like for example strokes) and bleeding events in patients who undergo a normalisation of their heart rhythm disturbance. Fondaparinux will be compared with Heparin and tablets containing Vitamin-K-Antagonists (Phenprocoumon, Fluindione, or Warfarin).

NCT ID: NCT00437242 Terminated - Atrial Fibrillation Clinical Trials

Odiparcil QT Definitive Study

Start date: October 2006
Phase: Phase 1
Study type: Interventional

This study is being completed to demonstrate the lack of effect of repeat dosing with Odiparcil on the QTc interval.

NCT ID: NCT00402363 Completed - Atrial Fibrillation Clinical Trials

Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

Start date: November 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate efficacy and safety of Omacor (omega-3-acid ethyl esters) in patients with recurrent, symptomatic atrial fibrillation.

NCT ID: NCT00244725 Completed - Pulmonary Embolism Clinical Trials

Odiparcil For The Prevention Of Venous Thromboembolism

Start date: September 2005
Phase: Phase 2
Study type: Interventional

Odiparcil is being studied to determine if it can prevent blood clots from forming after a total knee replacement and also to prove that odiparcil is safe.

NCT ID: NCT00240643 Completed - Atrial Fibrillation Clinical Trials

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Start date: November 2005
Phase: Phase 2
Study type: Interventional

This study will allow determination of the pharmacokinetic and pharmacodynamics of SB424323 in a relevant population. The data from this study will be used along with other data to aid in choosing the most appropriate dose for the later phase study.

NCT ID: NCT00041496 Completed - Clinical trials for Fibrillation, Atrial

Prevention Of Recurrence Of Atrial Fibrillation

Start date: November 2001
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the study drug is effective in preventing the recurrence of atrial fibrillation (an abnormal heart rhythm).